Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.82 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.82 |
| ▸ | MAPT | P10636 | 1/20 | 0.78 |
| ▸ | BLM | P54132 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.60 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.60 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.60 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.60 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.60 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.60 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.60 |
| ▸ | HTR1A | P08908 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | PGR | P06401 | 1/20 | 0.60 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.60 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.60 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.60 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16353067 | 0.95 | ADRA2A (0.82) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL8087675 | 0.93 | ADRA2A (0.78) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL1984572 | 0.93 | ADRA2A (0.78) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL28047745 | 0.92 | ADRA2A (0.69) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Iodide SCHEMBL15378186 | 0.91 | ADRA2A (0.75) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Iodide SCHEMBL1980845 | 0.91 | ADRA2A (0.75) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL41537 | 0.90 | ADRA2A (1.00) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL16352919 | 0.89 | ADRA2A (0.72) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL2821312 | 0.88 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL1643328 | 0.88 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023174433-A1 | SOLID, SEMISOLID, OR LIQUID COMPOSITIONS FOR AUGMENTING THE STABILITY, PERMEABILITY AND BIOAVAILABILITY OF ACTIVE PHARMACEUTICAL SUBSTANCES | Smart Pharmaceutical (Suzhou) Co., Ltd. (CN) | 2023-09-21 | — | — | WO | claimed |
| CN-116725011-A | Promotion of germination of mung bean seeds by exogenous choline glutaric acid | 西北农林科技大学 | 2023-09-12 | — | — | CN | claimed |
| WO-2023174433-A1 | SOLID, SEMISOLID, OR LIQUID COMPOSITIONS FOR AUGMENTING THE STABILITY, PERMEABILITY AND BIOAVAILABILITY OF ACTIVE PHARMACEUTICAL SUBSTANCES | Smart Pharmaceutical (Suzhou) Co., Ltd. (CN) | 2023-09-21 | — | — | WO | disclosed |
| CN-116725011-A | Promotion of germination of mung bean seeds by exogenous choline glutaric acid | 西北农林科技大学 | 2023-09-12 | — | — | CN | disclosed |
| CN-116725011-A | Promotion of germination of mung bean seeds by exogenous choline glutaric acid | 西北农林科技大学 | 2023-09-12 | — | — | CN | disclosed |
| US-11720018-B2 | Chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20230152692-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20230152692-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20220257767-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-08-18 | — | — | US | disclosed |
| EP-3946261-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | President And Fellows Of Harvard College (US) | 2022-02-09 | — | — | EP | disclosed |
| CN-113939273-A | Ionic liquids for drug delivery | 哈佛大学校长及研究员协会 | 2022-01-14 | — | — | CN | disclosed |
| US-20220004101-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-01-06 | — | — | US | disclosed |
| US-20210033969-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-02-04 | — | — | US | disclosed |
| WO-2020205409-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-10-08 | — | — | WO | disclosed |
| US-20180143532-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-05-24 | — | — | US | disclosed |
| US-20180086948-A1 | ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-03-29 | — | — | US | disclosed |
| US-20140377706-A1 | DEVELOPER FOR PHOTOSENSITIVE RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220257767-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | SLCO4C1, SLC47A1, ABCB11 | ADRA2A 1699/4885ADRA1A 1627/4885MAPT 170/4885 |
| US-20180086948-A1 | ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT | SLC9A1, FN1, EPCAM | ADRA2A 3217/4885ADRA1A 1359/4885MAPT 3241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.